These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32350118)

  • 1. Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.
    Mitchell KG; Diao L; Karpinets T; Negrao MV; Tran HT; Parra ER; Corsini EM; Reuben A; Federico L; Bernatchez C; Dejima H; Francisco-Cruz A; Wang J; Antonoff MB; Vaporciyan AA; Swisher SG; Cascone T; Wistuba II; Heymach JV; Gibbons DL; Zhang J; Haymaker CL; Sepesi B
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32350118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
    Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
    Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.
    Barrera L; Montes-Servín E; Hernandez-Martinez JM; Orozco-Morales M; Montes-Servín E; Michel-Tello D; Morales-Flores RA; Flores-Estrada D; Arrieta O
    Cancer Immunol Immunother; 2018 Sep; 67(9):1393-1406. PubMed ID: 29974189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.
    Zhang H; Zhang L; Zhu K; Shi B; Yin Y; Zhu J; Yue D; Zhang B; Wang C
    PLoS One; 2015; 10(5):e0126496. PubMed ID: 25950176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancer.
    Sitthideatphaiboon P; Santisukwongchote S; Khunsri S; Sathitruangsak C; Chantranuwat P; Vinayanuwattikun C; Sriuranpong V
    Clin Transl Oncol; 2020 Jul; 22(7):1117-1125. PubMed ID: 31754936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers.
    Ayers KL; Ma M; Debussche G; Corrigan D; McCafferty J; Lee K; Newman S; Zhou X; Hirsch FR; Mack PC; Liu JJ; Schadt EE; Chen R; Li SD
    BMC Cancer; 2021 Apr; 21(1):441. PubMed ID: 33882890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients.
    Barrera L; Montes-Servín E; Hernandez-Martinez JM; García-Vicente MLÁ; Montes-Servín E; Herrera-Martínez M; Crispín JC; Borbolla-Escoboza JR; Arrieta O
    Br J Cancer; 2017 Jul; 117(3):385-397. PubMed ID: 28632731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.
    Kobayashi N; Usui S; Kikuchi S; Goto Y; Sakai M; Onizuka M; Sato Y
    Lung Cancer; 2012 Feb; 75(2):223-7. PubMed ID: 21764477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort.
    Yuan C; Li N; Mao X; Liu Z; Ou W; Wang SY
    Thorac Cancer; 2017 Jul; 8(4):350-358. PubMed ID: 28544400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative platelet to lymphocyte and neutrophil to lymphocyte ratios are independent prognostic factors for patients undergoing lung cancer radical surgery: A single institutional cohort study.
    Lan H; Zhou L; Chi D; Zhou Q; Tang X; Zhu D; Yue J; Liu B
    Oncotarget; 2017 May; 8(21):35301-35310. PubMed ID: 27845912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.
    Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
    Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):248-255. PubMed ID: 32074540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer.
    Schernberg A; Mezquita L; Boros A; Botticella A; Caramella C; Besse B; Escande A; Planchard D; Le Péchoux C; Deutsch E
    PLoS One; 2018; 13(10):e0204490. PubMed ID: 30304046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
    Sun H; Hu P; Shen H; Dong W; Zhang T; Liu Q; Du J
    PLoS One; 2015; 10(12):e0144663. PubMed ID: 26656866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
    Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
    Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of preoperative circulating CD44⁺ lymphocytes and neutrophils predict poor survival for non-small cell lung cancer patients.
    Yang SZ; Ji WH; Mao WM; Ling ZQ
    Clin Chim Acta; 2015 Jan; 439():172-7. PubMed ID: 25451952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.
    Jeong E; Hyun SH; Moon SH; Cho YS; Kim BT; Lee KH
    Medicine (Baltimore); 2017 Feb; 96(5):e5935. PubMed ID: 28151879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood immune cell biomarkers in lung cancer.
    Riemann D; Cwikowski M; Turzer S; Giese T; Grallert M; Schütte W; Seliger B
    Clin Exp Immunol; 2019 Feb; 195(2):179-189. PubMed ID: 30246868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in PD-L1 expression and CD8
    Choe EA; Cha YJ; Kim JH; Pyo KH; Hong MH; Park SY; Shim HS; Jung I; Lee CY; Cho BC; Kim HR
    Lung Cancer; 2019 Oct; 136():30-36. PubMed ID: 31421259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.